Dr Lal PathLabs is focusing on “inorganic growth” to expand its footprint across India, particularly in the southern and western regions where the diagnostics chain has little presence.
Inorganic growth arises from mergers or takeovers rather than an increase in the company's own business activity.
The company’s strategy comes as the sector faces a temporary slowdown owing to demonetisation and increased competition. Its other initiatives include value-added services to customers, such as the collation of test results of last 10 visits and a focus on preventive healthcare checks.
Seventy per cent of Dr Lal PathLabs’s business comes from north India and around